Product Name

Diclofenac Sodium

CAS Number

15307-79-6

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:
Diclofenac Sodium
CAS Number:
15307-79-6
Indication:
For the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.
Mode of Action:

The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.

Pharmacodynamics:

Diclofenac is an acetic acid nonsteroidal antiinflammatory drug (NSAID) with analgesic and antipyretic properties. Diclofenac is used to treat pain, dysmenorrhea, ocular inflammation, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and actinic keratosis

Toxicity:

Symptoms of overdose include loss of consciousness, increased intracranial pressure, and aspiration pneumonitis. LD50=390mg/kg (orally in mice)

IUPAC:
Acetic acid, o-(2, 6-dichloroanilino)phenyl-, monosodium salt, Benzeneacetic acid, 2-((2, 6-dichlorophenyl)amino)-, monosodium salt, Feloran, Sodium (2-((2, 6-dichlorophenyl)amino)phenyl)acetate
ATC:
M01AB05″ M02AA15″ S01BC03″ D11AX18
PubChem:
3033
DrugBank:
APRD00527
Formula:
C14 H11 N1 O2
Molecular Mass:
318.134
Synonyms:
(o-(2,6-Dichloroanilino)phenyl)acetic acid monosodium salt, (o-(2,6-Dichloroanilino)phenyl)acetic acid sodium salt, 2-((2,6-Dichlorophenyl)amino)benzeneacetic acid monosodium salt, Abitren, Allvoran, Anthraxiton, Assaren, Ba 47210, Batafil, Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monosodium salt, Blesin, CCRIS 1909, Delimon, Delphimix, DIC075V, Dichronic, Diclofenac sodium, Diclofenac sodium topical gel, Diclophenac sodium, EINECS 239-346-4, GP 45840, Kriplex, Neriodin, Orthophen, Ortofen, Pennsaid, Prophenatin, Sodium (o-((2,6-dichlorophenyl)amino)phenyl)acetate, Sodium (o-(2,6-dichloroanilino)phenyl) acetate, Sodium (o-(2,6-dichloroanilino)phenyl)acetate, Sodium diclofenac, Solaraze, Tsudohmin, UNII-QTG126297Q, Urigon, Valetan, Voltaren, Voltaren Gel, Voltaren ophthalmic, Voltaren-XR, Voltarene, Voltarol, Vonafec, Vurdon
AHFS Code:
28:08.04.92, 28:08.04.08
General Reference:
General Reference:

 

  1. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006 Jun 3;332(7553):1302-8. Pubmed
  2. Solomon DH, Avorn J, Sturmer T, Glynn RJ, Mogun H, Schneeweiss S: Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006 May;54(5):1378-89. Pubmed
  3. FitzGerald GA, Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001 Aug 9;345(6):433-42. Pubmed
  4. Graham DJ: COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA. 2006 Oct 4;296(13):1653-6. Epub 2006 Sep 12. Pubmed
  5. Brater DC: Renal effects of cyclooxygyenase-2-selective inhibitors. J Pain Symptom Manage. 2002 Apr;23(4 Suppl):S15-20; discussion S21-3. Pubmed
  6. Sigma Aldrich Link
  7. Gan TJ: Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010 Jul;26(7):1715-31. Pubmed

 

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210. 

Ask us about this product

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants
  • Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any submission type based on specific customer requirements

Find an API Product

SEARCH
Generic filters